ADA Scientific Sessions 2025 Abstract

Safety, Tolerability, PK, and Efficacy of MET097—A Next-Generation Nutrient-Stimulated Hormone Peptide Analog for Chronic Weight Management

By Mark Stroh, James S. Minnion, Stephanie Ranck, Steven P. Marso

Trial in peopleInterventions

The paper

Mark Stroh, James S. Minnion, Stephanie Ranck, Steven P. Marso

London

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 753-P

doi.org/10.2337/db25-753-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes